EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform

Ligia Selagea, Alok Mishra, Monika Anand, James Ross, Carol Tucker-Burden, Jun Kong, Daniel J. Brat

Research output: Contribution to journalArticle

Abstract

We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-b signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-β is known to drive themesenchymal transcriptional signature inGBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-β expression, as well as enhanced nuclear translocation and DNA-binding activity, leading to upregulation of C/EBP-β transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-β also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-β [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-β isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-β pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-β leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-β signaling axis could attenuate malignant behavior of glioblastoma.

Original languageEnglish (US)
Pages (from-to)4098-4108
Number of pages11
JournalFASEB Journal
Volume30
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

CCAAT-Enhancer-Binding Proteins
Epidermal Growth Factor Receptor
Glioma
Protein Isoforms
Up-Regulation
Liver
Transcription
Glioblastoma
Dissection
Proteins
Protein Biosynthesis
Interleukin-6
Genes
Chemical activation
Cytokines

Keywords

  • Cell signaling
  • Glioblastoma
  • LAP
  • LIP

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform. / Selagea, Ligia; Mishra, Alok; Anand, Monika; Ross, James; Tucker-Burden, Carol; Kong, Jun; Brat, Daniel J.

In: FASEB Journal, Vol. 30, No. 12, 01.12.2016, p. 4098-4108.

Research output: Contribution to journalArticle

Selagea, L, Mishra, A, Anand, M, Ross, J, Tucker-Burden, C, Kong, J & Brat, DJ 2016, 'EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform', FASEB Journal, vol. 30, no. 12, pp. 4098-4108. https://doi.org/10.1096/fj.201600550R
Selagea, Ligia ; Mishra, Alok ; Anand, Monika ; Ross, James ; Tucker-Burden, Carol ; Kong, Jun ; Brat, Daniel J. / EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform. In: FASEB Journal. 2016 ; Vol. 30, No. 12. pp. 4098-4108.
@article{20572e99e7264b568d2b7e6d629ff324,
title = "EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform",
abstract = "We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-b signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-β is known to drive themesenchymal transcriptional signature inGBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-β expression, as well as enhanced nuclear translocation and DNA-binding activity, leading to upregulation of C/EBP-β transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-β also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-β [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-β isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-β pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-β leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-β signaling axis could attenuate malignant behavior of glioblastoma.",
keywords = "Cell signaling, Glioblastoma, LAP, LIP",
author = "Ligia Selagea and Alok Mishra and Monika Anand and James Ross and Carol Tucker-Burden and Jun Kong and Brat, {Daniel J.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1096/fj.201600550R",
language = "English (US)",
volume = "30",
pages = "4098--4108",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "12",

}

TY - JOUR

T1 - EGFR and C/EBP-β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-β isoform

AU - Selagea, Ligia

AU - Mishra, Alok

AU - Anand, Monika

AU - Ross, James

AU - Tucker-Burden, Carol

AU - Kong, Jun

AU - Brat, Daniel J.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-b signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-β is known to drive themesenchymal transcriptional signature inGBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-β expression, as well as enhanced nuclear translocation and DNA-binding activity, leading to upregulation of C/EBP-β transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-β also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-β [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-β isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-β pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-β leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-β signaling axis could attenuate malignant behavior of glioblastoma.

AB - We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-b signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-β is known to drive themesenchymal transcriptional signature inGBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-β expression, as well as enhanced nuclear translocation and DNA-binding activity, leading to upregulation of C/EBP-β transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-β also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-β [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-β isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-β pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-β leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-β signaling axis could attenuate malignant behavior of glioblastoma.

KW - Cell signaling

KW - Glioblastoma

KW - LAP

KW - LIP

UR - http://www.scopus.com/inward/record.url?scp=85002397992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002397992&partnerID=8YFLogxK

U2 - 10.1096/fj.201600550R

DO - 10.1096/fj.201600550R

M3 - Article

C2 - 27572958

AN - SCOPUS:85002397992

VL - 30

SP - 4098

EP - 4108

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 12

ER -